For example, CRP reduces endothelial nitric oxide synthase (eNOS) activity which subsequently reduces vasodilator effects of NO and increases vasoconstrictor effects of Endothelin-1 (ET-1) all of which increases the chances of atherosclerosis and clot formation [42]. This evidence concerns the gene EDN1 and atherosclerosis.